People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination
Creators
- 1. University of Illinois at Chicago
- 2. Brown University
- 3. University of Chicago
- 4. Loyola University
- 5. Argonne National Laboratory
Description
Progress toward hepatitis C virus (HCV) elimination in the United States is not on track to meet targets set by the World Health Organization, as the opioid crisis continues to drive both injection drug use and increasing HCV incidence. A pragmatic approach to achieving this is using a microelimination approach of focusing on high-risk populations such as people who inject drugs (PWID). Computational models are useful in understanding the complex interplay of individual, social, and structural level factors that might alter HCV incidence, prevalence, transmission, and treatment uptake to achieve HCV microelimination. However, these models need to be informed with realistic sociodemographic, risk behavior and network estimates on PWID. We conducted a meta-analysis of research studies spanning 20 years of research and interventions with PWID in metropolitan Chicago to produce parameters for a synthetic population for realistic computational models (e.g., agent-based models). We then fit an exponential random graph model (ERGM) using the network estimates from the meta-analysis in order to develop the network component of the synthetic population.
Data availability
All data and documentation files are available from the Open Science Framework database (DOI 10.17605/OSF.IO/4PXZW).
Files
journal.pone.0248850.pdf
Files
(1.7 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:c4b928d70d470363a705c901885acfed |
902.9 kB | Preview Download |
|
Supporting information md5:268aadc70fed810cbc8ce5a40299ba3e |
776.5 kB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pone.0248850
- Other
- oai:uchicago.tind.io:5889
Related works
- Cites
- https://doi.org/10.1101/2021.02.24.21252385 (URL)
Funding
- National Institute of General Medical Sciences
- R01GM121600
- National Institute of Drug Abuse
- R01DA043484